Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.

  title={Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.},
  author={Dejan Cagli{\vc} and Anja Globisch and Maik Kindermann and Ngee Han Lim and Volker Jeske and H. -P. Juretschke and Eckart Dr. Bartnik and Klaus Ulrich Dr. Weithmann and Hideaki Nagase and Boris Turk and Karl Ulrich Wendt},
  journal={Bioorganic \& medicinal chemistry},
  volume={19 3},

Figures and Tables from this paper

Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization.

The design and synthesis of a near-infrared quenched activity-based probe (qABP) is presented that selectively targets cathepsin S which is highly expressed in immune cells and retained both in vitro and in vivo.

Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin

This approach validates cathepsin B as a promising diagnostic and theranostic target in cancer and other inflammation-associated diseases.

In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin S Substrate**

The lipidated probe provided a prolonged and strongly fluorescent signal in tumors when compared to the very similar non-lipidated probe, demonstrating that non-invasive tumor identification is feasable.

Assessment of murine collagen-induced arthritis by longitudinal non-invasive duplexed molecular optical imaging.

It is demonstrated that longitudinal non-invasive duplexed optical fluorescence imaging provides a simple assessment of arthritic disease activity within the joints of mice following the induction of CIA and may represent a powerful tool to monitor the efficacy of drug treatments in preclinical studies.

Detection of DSS-induced gastrointestinal mucositis in mice by non-invasive optical near-infrared (NIR) imaging of cathepsin activity

The investigation suggests that NIR optical imaging can detect cathepsin-dependent probe cleavage non-invasively in animals with DSS-induced IBD, and could be coupled with colonoscopy investigation to aid in the sampling and the diagnostics of IBD.

Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages

This study shows that exposure to silica, alum and polystyrene particulates induces IL-1β release from macrophages, through lysosomal destabilization, and supports the emerging significance of CTSS as a regulator of the innate immune response.

Cysteine cathepsins and their potential in clinical therapy and biomarker discovery

This review will present cysteine cathepsin roles in disease progression and discuss their potential relevance as prognostic and diagnostic biomarkers.



Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.

NIRF-ABPs can be used to monitor small-molecule inhibition of protease targets both biochemically and by direct imaging methods, and are potentially valuable new imaging agents for disease diagnosis and powerful tools for preclinical and clinical testing of small-mite therapeutic agents in vivo.

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.

Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

The current view on cathepsins as an emerging group of targets for several diseases and the development ofCathepsin K and S inhibitors for treatment of osteoporosis and various immune disorders are discussed.

Dynamic imaging of protease activity with fluorescently quenched activity-based probes

The design and synthesis of a selective, cell-permeable qABP is reported, used to monitor real-time protease activity in live human cells with fluorescence microscopy techniques as well as standard biochemical methods.

Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model

It is concluded that the pharmacokinetic properties of JPM-OEt, which result in poor bioavailability, may prohibit its use for stand-alone treatment of solid mammary cancers and their lung metastases.

Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor

JNJ 10329670 is a highly potent, orally available, high-affinity cathepsin S inhibitor, that represents a novel class of immunosuppressive compounds and was shown to block the proteolysis of the invariant chain in vivo by using immunocompromised mice injected with human peripheral blood mononuclear cells (PBMCs).

Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis

It is reported that both cysteine cathepsins B and S and matrix metalloproteases-1, -3 and -13 are detected in patient synovial fluid samples with significantly higher levels detected in rheumatoid arthritis patients.

Mechanism-based profiling of enzyme families.

Drawing conceptual and methodological inspiration from the success of genomic technologies, the field of proteomics has introduced several strategies for the global analysis of protein expression and function.

Structure of a Cys25-->Ser mutant of human cathepsin S.

Cathepsin S (EC, a cysteine proteinase of the papain superfamily, plays a critical role in the generation of a major histocompatibility complex (MHC) class II restricted T-cell response by